Clinical Trial Update: Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers

View source ↗

Summary

Everest Detection, Inc. is conducting a clinical trial to identify and validate blood-based biomarkers for early detection of asymptomatic lung cancer in high-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Everest Detection, Inc. | Conditions: Lung Cancers | Status: RECRUITING